Position in LBRX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$593,392
New position
Shares Held
24,063
first reported quarter
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Calamos Advisors LLC holds $103,200,124 across 23 Biotechnology names. LBRX ranks #19 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
77,886 | $34,779,214 | |
| 2 | RPRX |
Royalty Pharma plc
|
437,090 | $20,967,207 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,793 | $9,111,743 | |
| 4 | INSM |
INSMED Inc
|
36,373 | $5,947,712 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
73,600 | $4,756,768 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
20,860 | $4,164,698 | |
| 7 | ASND |
Ascendis Pharma A/S
|
15,390 | $3,520,154 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
43,832 | $3,074,814 |
All Filings in LBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $593,392 | 24,063 | Shares | Other | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||